WebClinical Outcomes Following Primary Prevention Implantable Cardioverter Defibrillator (ICD) Implantation Among Older Patients With Hypertrophic Cardiomyopathy (HCM) Conference Paper. Full Text. Link to Item; Duke Authors . Al-Khatib, Sana Mustapha; Cited Authors . Goldstein, SA; Kennedy, K; Friedman, D; Al-Khatib, SM; Wang, A Published Date . 2024 WebJan 22, 2016 · SNOWMASS, COLO. – Since the 2011 release of the current American College of Cardiology/American Heart Association guidelines on hypertrophic cardiomyopathy, several new evidence-based tools have emerged as being helpful in decision making regarding which patients should receive an implantable cardioverter-defibrillator (ICD) for …
Prevention of sudden cardiac death in hypertrophic cardiomyopathy
WebAug 12, 2024 · The annual rate of appropriate ICD therapy (ie, antitachycardia pacing [ATP] or shocks) in patients with HCM receiving a primary prevention ICD varies between 3%/y … WebJul 1, 2024 · Introduction. Hypertrophic cardiomyopathy (HCM) is a cardiac disorder with an incidence of 1 in 200 and is associated with heart failure, embolism and sudden cardiac death (SCD) ().The incidence of sudden death in HCM is low, around 0.7–1% per annum, and often young patients are affected ().The use of implantable cardioverter-defibrillator (ICD) … c applications
2024 AHA/ACC Guideline for the Diagnosis and …
WebWe also discuss the role of modern ICD therapy in the primary prevention of sudden death in patients with HCM. Epidemiology of Hypertrophic Cardiomyopathy and Sudden Cardiac … WebMay 16, 2024 · Sowohl in den Leitlinien der European Society of Cardiology (ESC) als auch jenen der American Heart Association (AHA) stellt die ICD-Implantation bei nichtischämischer CMP (NICMP) bei einer linksventrikulären Ejektionsfraktion ≤ 35 % und zumindest dreimonatiger optimaler medikamentöser Therapie sowie einer … WebBackground -Identification of people with hypertrophic cardiomyopathy (HCM) who are at risk of sudden cardiac death (SCD) and require prophylactic implantable cardioverter defibrillator (ICD) is challenging. In 2014, the European Society of brittan wagner